Clinical Trial Update: MMF Influence on HCV Viral Evolution After Liver Transplantation

View source ↗

Summary

A completed Mayo Clinic-sponsored clinical trial studied how mycophenolate mofetil (MMF) affects hepatitis C virus evolution in liver transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

Sponsor: Mayo Clinic | Conditions: HCV Infection, Liver Transplantation | Status: COMPLETED